The Lewis y antigen can also increase the tyrosine phosphorylation of MUC1 receptors in ovarian cancer by activating downstream β-catenin, PI3K/Akt and ERK/MAPK signaling pathways associated with apoptosis and chemoresistance [21,22]. The gene discussed is AKT1; the disease is ovarian carcinoma.